Agilon Health (NYSE:AGL) Hits New 1-Year High – What’s Next?

Agilon Health, Inc. (NYSE:AGL) reached a new 52-week high during trading on Monday . The company traded as high as $119.07 and last traded at $114.2640, with a volume of 23927 shares changing hands. The stock had previously closed at $113.80.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Robert W. Baird lifted their price objective on shares of Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a research note on Monday, May 4th. Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Finally, TD Cowen reiterated a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $58.73.

Agilon Health Stock Down 1.7%

The company has a 50-day moving average of $70.62 and a 200-day moving average of $35.48. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.85 billion, a price-to-earnings ratio of -5.16 and a beta of 3.00.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. On average, equities analysts predict that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Trading of Agilon Health

Several large investors have recently bought and sold shares of the stock. North Peak Capital Management LLC increased its stake in Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after buying an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Agilon Health by 1,346.6% during the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after buying an additional 9,505,837 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Agilon Health by 30.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after acquiring an additional 1,893,434 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Agilon Health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock valued at $4,944,000 after acquiring an additional 35,054 shares during the period.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.